Antacid Market Size, Company Revenue Share, Key Drivers & Trend Analysis, 2023–2032
Ngày đăng: 04-09-2023 |
Ngày cập nhật: 04-09-2023
The global market size for antacids reached $6.03 billion in 2022 and is projected to attain $8.51 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.9% during the forecast period. The primary driving force behind the growth in market revenue is the increasing prevalence of Gastroesophageal Reflux Disease (GERD) and peptic ulcers. These conditions often necessitate the use of antacids to alleviate symptoms like heartburn and acid reflux.
The surge in GERD and peptic ulcers cases can be attributed to factors such as the aging population and unhealthy lifestyle choices including smoking, alcohol consumption, and poor dietary habits. This has led to a higher demand for antacids. Additionally, the growing awareness among patients regarding the safety and effectiveness of antacids is also contributing to market expansion.
Another factor propelling the revenue growth in the antacid market is the preference for Over-the-Counter (OTC) antacids. Consumers find OTC antacids appealing due to their easy accessibility, affordability, and convenience. Furthermore, the adoption of e-commerce platforms for purchasing OTC antacids is bolstering market growth.
The market is also benefiting from the increasing incidence of acid reflux in pregnant women. Hormonal changes during pregnancy can lead to a relaxed lower esophageal sphincter, resulting in acid reflux. Antacids are commonly chosen by pregnant women to manage these symptoms as they are perceived to be safe for use during pregnancy.
Diverse antacid options available in tablet, liquid, and powder forms are playing a pivotal role in driving market revenue. Manufacturers are introducing innovative products to cater to evolving consumer preferences. For instance, chewable antacid tablets are gaining popularity due to their convenience and rapid action.
However, the presence of alternative treatments like Proton Pump Inhibitors (PPIs) and Histamine-2 Receptor Antagonists (H2RAs) for GERD and peptic ulcers could potentially limit market growth. Healthcare providers often prescribe PPIs and H2RAs instead of antacids due to perceived higher efficacy.
Despite these growth factors, concerns about the potential adverse effects of long-term antacid use, such as diarrhea, constipation, and renal problems, may restrain market growth. Additionally, the availability of generic antacid options at lower costs could also moderately impede revenue expansion.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/7192
Competitive landscape:
The antacid market's growth and dynamics are influenced by several driving factors that shape its demand, trends, and overall trajectory. These factors include:
To know more about the report @ https://www.reportsanddata.com/report-detail/antacid-market
Segments covered in the report:
Segments covered by Application Outlook, End-use Industry, Regional Outlook
By Product Type Outlook
Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.
Explore Trending Report:
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
Browse Upcoming Reports: https://www.reportsanddata.com/upcoming-reports
The surge in GERD and peptic ulcers cases can be attributed to factors such as the aging population and unhealthy lifestyle choices including smoking, alcohol consumption, and poor dietary habits. This has led to a higher demand for antacids. Additionally, the growing awareness among patients regarding the safety and effectiveness of antacids is also contributing to market expansion.
Another factor propelling the revenue growth in the antacid market is the preference for Over-the-Counter (OTC) antacids. Consumers find OTC antacids appealing due to their easy accessibility, affordability, and convenience. Furthermore, the adoption of e-commerce platforms for purchasing OTC antacids is bolstering market growth.
The market is also benefiting from the increasing incidence of acid reflux in pregnant women. Hormonal changes during pregnancy can lead to a relaxed lower esophageal sphincter, resulting in acid reflux. Antacids are commonly chosen by pregnant women to manage these symptoms as they are perceived to be safe for use during pregnancy.
Diverse antacid options available in tablet, liquid, and powder forms are playing a pivotal role in driving market revenue. Manufacturers are introducing innovative products to cater to evolving consumer preferences. For instance, chewable antacid tablets are gaining popularity due to their convenience and rapid action.
However, the presence of alternative treatments like Proton Pump Inhibitors (PPIs) and Histamine-2 Receptor Antagonists (H2RAs) for GERD and peptic ulcers could potentially limit market growth. Healthcare providers often prescribe PPIs and H2RAs instead of antacids due to perceived higher efficacy.
Despite these growth factors, concerns about the potential adverse effects of long-term antacid use, such as diarrhea, constipation, and renal problems, may restrain market growth. Additionally, the availability of generic antacid options at lower costs could also moderately impede revenue expansion.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/7192
Competitive landscape:
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis AG
- Bayer AG
- Procter & Gamble Co.
- Sanofi S.A.
- Perrigo Company plc
- Reckitt Benckiser Group plc
- Church & Dwight Co. Inc.
- Sun Pharmaceutical Industries Ltd.
The antacid market's growth and dynamics are influenced by several driving factors that shape its demand, trends, and overall trajectory. These factors include:
- Lifestyle Changes and Dietary Habits: Modern lifestyles often involve irregular eating patterns, consumption of processed foods, and high intake of spicy or acidic foods. These habits can lead to increased instances of acid reflux and heartburn, driving the demand for antacids as a solution.
- Prevalence of Gastrointestinal Disorders: Conditions such as gastroesophageal reflux disease (GERD), gastritis, and peptic ulcers are on the rise due to factors like stress, poor diet, and obesity. Antacids provide relief from the discomfort associated with these disorders, boosting their demand.
- Rising Aging Population: As the global population ages, the incidence of conditions like GERD tends to increase. Older individuals are more susceptible to these digestive issues, resulting in a higher need for antacid medications.
- Urbanization and Stress: Urbanization often brings about increased stress levels, which can contribute to digestive problems. Stress can exacerbate existing gastrointestinal conditions, further fueling the demand for antacids.
- Over-the-Counter (OTC) Availability: The availability of antacids as over-the-counter medications makes them easily accessible to consumers. This convenience encourages individuals to self-treat minor digestive discomfort, contributing to market growth.
- Awareness and Health Education: Growing awareness about digestive health and the availability of information through the internet and healthcare providers lead individuals to seek solutions for their digestive issues, including antacids.
- Innovations in Product Formulations: Manufacturers continually develop new formulations that provide rapid relief and longer-lasting effects. Innovations such as chewable tablets, liquid suspensions, and effervescent powders attract consumers looking for convenient and effective solutions.
- Global Dietary Trends: Changes in dietary preferences, such as the consumption of spicy or fatty foods, can trigger acid reflux and heartburn. This aligns with the need for antacids to alleviate the resulting discomfort.
- Increasing Healthcare Expenditure: As disposable incomes rise, people are more likely to spend on healthcare products, including antacids, to manage their digestive issues effectively.
- Pharmaceutical Industry Growth: The pharmaceutical sector's advancements in research and development lead to the creation of more potent and targeted antacid formulations. This drives consumer confidence and demand for these products.
- Economic and Cultural Factors: Cultural factors and eating habits specific to certain regions can contribute to a higher demand for antacids in those areas. Economic growth can also play a role in increasing access to and affordability of such products.
- Global Food Trends: As global cuisines become more diverse and accessible, people may experiment with new foods that could trigger digestive discomfort, further boosting the demand for antacids.
To know more about the report @ https://www.reportsanddata.com/report-detail/antacid-market
Segments covered in the report:
Segments covered by Application Outlook, End-use Industry, Regional Outlook
By Product Type Outlook
- Tablets
- Liquid
- Chews
- Pharmacies
- Supermarkets/Hypermarkets
- Online
- North America (U.S.A., Canada, Mexico)
- Europe (Italy, U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.
Explore Trending Report:
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
Browse Upcoming Reports: https://www.reportsanddata.com/upcoming-reports
